These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31392326)

  • 1. Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data.
    Woodward M; Marko A; Galea S; Eagel B; Straus W
    Open Forum Infect Dis; 2019 Aug; 6(8):. PubMed ID: 31392326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
    Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
    Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-licensure safety surveillance of zoster vaccine live (Zostavax®) in the United States, Vaccine Adverse Event Reporting System (VAERS), 2006-2015.
    Miller ER; Lewis P; Shimabukuro TT; Su J; Moro P; Woo EJ; Jankosky C; Cano M
    Hum Vaccin Immunother; 2018; 14(8):1963-1969. PubMed ID: 29580194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP).
    Goulleret N; Mauvisseau E; Essevaz-Roulet M; Quinlivan M; Breuer J
    Vaccine; 2010 Aug; 28(36):5878-82. PubMed ID: 20600487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postlicensure safety surveillance for varicella vaccine.
    Wise RP; Salive ME; Braun MM; Mootrey GT; Seward JF; Rider LG; Krause PR
    JAMA; 2000 Sep; 284(10):1271-9. PubMed ID: 10979114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The postmarketing safety profile of varicella vaccine.
    Sharrar RG; LaRussa P; Galea SA; Steinberg SP; Sweet AR; Keatley RM; Wells ME; Stephenson WP; Gershon AA
    Vaccine; 2000 Nov; 19(7-8):916-23. PubMed ID: 11115716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merck/Centers for Disease Control and Prevention Varicella Vaccine Pregnancy Registry: 19-Year Summary of Data From Inception Through Closure, 1995-2013.
    Willis ED; Marko AM; Rasmussen SA; McGee M; Broder KR; Marin M
    J Infect Dis; 2022 Oct; 226(Suppl 4):S441-S449. PubMed ID: 36265854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Parrino J; McNeil SA; Lawrence SJ; Kimby E; Pagnoni MF; Stek JE; Zhao Y; Chan IS; Kaplan SS
    Vaccine; 2017 Mar; 35(14):1764-1769. PubMed ID: 28268074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of Vaccine-Strain Varicella-Zoster Virus: A Systematic Review.
    Marin M; Leung J; Gershon AA
    Pediatrics; 2019 Sep; 144(3):. PubMed ID: 31471448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Second-Dose Single-Antigen Varicella Vaccine.
    Su JR; Leroy Z; Lewis PW; Haber P; Marin M; Leung J; Woo EJ; Shimabukuro TT
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28174201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmarketing evaluation of the safety and effectiveness of varicella vaccine.
    Black S; Shinefield H; Ray P; Lewis E; Hansen J; Schwalbe J; Coplan P; Sharrar R; Guess H
    Pediatr Infect Dis J; 1999 Dec; 18(12):1041-6. PubMed ID: 10608621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults.
    Choi WS; Choi JH; Choi JY; Eom JS; Kim SI; Pai H; Peck KR; Sohn JW; Cheong HJ
    J Korean Med Sci; 2016 Jan; 31(1):13-7. PubMed ID: 26770032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.
    Patel MS; Gebremariam A; Davis MM
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
    Mullane KM; Morrison VA; Camacho LH; Arvin A; McNeil SA; Durrand J; Campbell B; Su SC; Chan ISF; Parrino J; Kaplan SS; Popmihajlov Z; Annunziato PW;
    Lancet Infect Dis; 2019 Sep; 19(9):1001-1012. PubMed ID: 31399378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
    Chaves SS; Haber P; Walton K; Wise RP; Izurieta HS; Schmid DS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S170-7. PubMed ID: 18419393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a two-dose live attenuated varicella vaccine given to adults following autologous hematopoietic stem cell transplantation.
    Sasadeusz J; Prince HM; Schwarer A; Szer J; Stork A; Bock HL; Povey M; Nicholson O; Innis BL
    Transpl Infect Dis; 2014 Dec; 16(6):1024-31. PubMed ID: 25272081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of varicella (VZV) vaccination: an update for the clinician.
    Wang L; Zhu L; Zhu H
    Ther Adv Vaccines; 2016 Jan; 4(1-2):20-31. PubMed ID: 27551429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of the varicella vaccine (Oka vaccine strain) based on reported cases from 2005 to 2015 in Japan.
    Yoshikawa T; Ando Y; Nakagawa T; Gomi Y
    Vaccine; 2016 Sep; 34(41):4943-4947. PubMed ID: 27591104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.